Your browser doesn't support javascript.
loading
PI3K inhibition results in enhanced HER signaling and acquired ERK dependency in HER2-overexpressing breast cancer.
Serra, V; Scaltriti, M; Prudkin, L; Eichhorn, P J A; Ibrahim, Y H; Chandarlapaty, S; Markman, B; Rodriguez, O; Guzman, M; Rodriguez, S; Gili, M; Russillo, M; Parra, J L; Singh, S; Arribas, J; Rosen, N; Baselga, J.
Affiliation
  • Serra V; Experimental Therapeutics Program, Vall d'Hebron Institute of Oncology, Barcelona, Spain.
Oncogene ; 30(22): 2547-57, 2011 Jun 02.
Article in En | MEDLINE | ID: mdl-21278786
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Receptor, ErbB-2 / Extracellular Signal-Regulated MAP Kinases / Protein Kinase Inhibitors / Phosphoinositide-3 Kinase Inhibitors Type of study: Prognostic_studies Limits: Female / Humans Language: En Journal: Oncogene Journal subject: BIOLOGIA MOLECULAR / NEOPLASIAS Year: 2011 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Receptor, ErbB-2 / Extracellular Signal-Regulated MAP Kinases / Protein Kinase Inhibitors / Phosphoinositide-3 Kinase Inhibitors Type of study: Prognostic_studies Limits: Female / Humans Language: En Journal: Oncogene Journal subject: BIOLOGIA MOLECULAR / NEOPLASIAS Year: 2011 Document type: Article Affiliation country: